J. Welsh

发表

CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer

J. Foekens, A. Sieuwerts, S. Thibodeau, 2013, Genome research.

Long‐Term Outcomes of Salvage Stereotactic Ablative Radiotherapy for Isolated Lung Recurrence of Non–Small Cell Lung Cancer: A Phase II Clinical Trial

Joe Y. Chang, D. Gomez, P. Balter, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1.

J. Weinstein, K. Coombes, G. Mills, 2012, Cancer discovery.

Planning Target Volume D95 and Mean Dose Should Be Considered for Optimal Local Control for Stereotactic Ablative Radiation Therapy.

Joe Y. Chang, D. Gomez, Steven H. Lin, 2016, International journal of radiation oncology, biology, physics.

Radiomics predicts clinical outcome in primary gastroesophageal junction adenocarcinoma treated by chemo/radiotherapy and surgery

Joe Y. Chang, L. Court, Steven H. Lin, 2017 .

7‐year follow‐up after stereotactic ablative radiotherapy for patients with stage I non–small cell lung cancer: Results of a phase 2 clinical trial

Joe Y. Chang, J. Roth, D. Gomez, 2017, Cancer.

Polymorphisms of the vascular endothelial growth factor gene and severe radiation pneumonitis in non‐small cell lung cancer patients treated with definitive radiotherapy

Q. Wei, Z. Liao, J. Welsh, 2012, Cancer science.

Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer

Peter Balter, Stephen G Swisher, Joe Y. Chang, 2012, Radiation oncology.

Combined treatment of non‐small cell lung cancer using radiotherapy and immunotherapy: challenges and updates

Jinming Yu, J. Welsh, V. Verma, 2021, Cancer communications.

Inhibition of the CD47-SIRPα axis for cancer therapy: A systematic review and meta-analysis of emerging clinical data

J. Welsh, D. Hong, M. Curran, 2022, Frontiers in Immunology.

Platinum-sensitive and platinum-resistant ovarian cancer tissues show differences in the relationships between mRNA levels of p53, ERCC1 and XPA.

J. Welsh, W. Bennett, E. Reed, 1996, International journal of oncology.

Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non–Small Cell Lung Cancer: Final Results of a Phase 2 Study

Joe Y. Chang, R. Mohan, Xiaodong Zhang, 2017, JAMA oncology.

Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer.

Joe Y. Chang, Edward S. Kim, P. Brown, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

cancer metastatic progression and chromosomal instability in colon , a novel noncoding RNA mapping to 8 q 24 , underlies CCAT 2 Material Supplemental

J. Foekens, A. Sieuwerts, S. Thibodeau, 2013 .

Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1.

Michael Peyton, Li Shen, John N Weinstein, 2012, Cancer discovery.

C-Met Inhibitor MK-8003 Radiosensitizes c-Met–Expressing Non–Small-Cell Lung Cancer Cells With Radiation-Induced c-Met–Expression

R. Komaki, V. Bhardwaj, J. Welsh, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Clinical outcomes after intensity-modulated proton therapy with concurrent chemotherapy for inoperable non-small cell lung cancer.

Zhongxing Liao, Pierre Blanchard, Z. Liao, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Association of epithelial-mesenchymal transition status with PD1/PDL1 expression and a distinct immunophenotype in non-small cell lung cancer: Implications for immunotherapy biomarkers.

Jing Wang, I. Wistuba, L. Byers, 2014 .

Lipid metabolism in tumor immunology and immunotherapy

J. Welsh, M. Cortez, H. Barsoumian, 2023, Frontiers in Oncology.

T-Cell Receptor Profiling and Prognosis After Stereotactic Body Radiation Therapy For Stage I Non-Small-Cell Lung Cancer

Z. Liao, J. Welsh, Xuan Pan, 2021, Frontiers in Immunology.

Can low-dose radiation therapy reduce the risk of mucormycosis in COVID-19 patients?

J. Welsh, D. Sharma, Rishabh Kumar, 2021, Journal of cancer research and therapeutics.